Craig-Hallum assists with sale of 2.85 million company common shares
By Devika Patel
Knoxville, Tenn., Feb. 28 - NeoGenomics, Inc. said it priced an $8.55 million public offering of stock with a $1.42 million greenshoe. The deal was announced Feb. 21.
The company will sell 2.85 million common shares at $3.00 per share. The price per share is a 4.15% discount to the Feb. 27 closing share price of $3.13.
Craig-Hallum Capital Group LLC is the bookrunning manager.
Settlement is expected March 5.
Proceeds will be used to pay down debt, and for general corporate and operations purposes.
Based in Fort Myers, Fla., NeoGenomics is a cancer genetics diagnostics testing company.
| Issuer: | NeoGenomics, Inc.
|
| Issue: | Common stock
|
| Amount: | $8.55 million
|
| Greenshoe: | $1,417,500
|
| Shares: | 2.85 million
|
| Price: | $3.00
|
| Warrants: | No
|
| Bookrunner: | Craig-Hallum Capital Group LLC
|
| Co-managers: | Ladenburg Thalmann & Co. Inc. and Emerging Growth Equities, Ltd.
|
| Announcement date: | Feb. 21
|
| Pricing date: | Feb. 28
|
| Settlement date: | March 5
|
| Stock symbol: | Nasdaq: NEO
|
| Stock price: | $3.13 at close Feb. 27
|
| Market capitalization: | $151.66 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
